NEXT-GEN STEROIDS Trademark

Trademark Overview

On Monday, March 2, 2020, a trademark application was filed for NEXT-GEN STEROIDS with the United States Patent and Trademark Office. The USPTO has given the NEXT-GEN STEROIDS trademark a serial number of 88817601. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 19, 2023. This trademark is owned by Sparrow Pharmaceuticals, Inc.. The NEXT-GEN STEROIDS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
next-gen steroids

General Information

Serial Number88817601
Word MarkNEXT-GEN STEROIDS
Filing DateMonday, March 2, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of allergic states, collagen diseases, dermatologic diseases, edematous states, endocrine disorders, gastrointestinal diseases, hematological disorders, infectious diseases, neoplastic diseases, nervous system disorders, ophthalmic diseases, respiratory disorders, and rheumatic disorders
Pseudo MarkNEXT GENERATION STEROIDS
Disclaimer with Predetermined Text"STEROIDS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSparrow Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97204

Trademark Events

Event DateEvent Description
Thursday, October 19, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 19, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, October 19, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 5, 2023NON-FINAL ACTION E-MAILED
Wednesday, July 5, 2023NON-FINAL ACTION WRITTEN
Sunday, July 2, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, June 7, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 21, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 23, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, November 22, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 24, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, November 22, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, November 22, 2020LETTER OF SUSPENSION E-MAILED
Sunday, November 22, 2020SUSPENSION LETTER WRITTEN
Saturday, November 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 5, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 27, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 27, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 27, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 20, 2020ASSIGNED TO EXAMINER
Sunday, March 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

steroids next diseases disorders states infectious hematological rheumatic neoplastic respiratory system gastrointestinal